Rege Nephro Co: Series C

Funding history

Jul 21, 2026Series C · This round$10.6M

Open-source healthcare data infrastructure unifying patient records for clinicians

$26MSeries A · Aug 27, 2026

Develops oligonucleotide therapeutics targeting chronic hepatitis B

$120MSeries C · Aug 27, 2026

Uses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia

$35MStrategic · Aug 27, 2026

AI platform automating medical coding and revenue assurance for health systems

$25MSeries B · Aug 26, 2026